Regeneron Pharmaceuticals
Price & Volume
Stats
See more52W Range | $475.76-$1,065.43 |
Market Cap | $60.1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $14.2B |
Revenue Growth (YoY) | 3.6% |
Gross Profit (12 Mos) | $6.7B |
Diluted EPS | $39.70 |
News
See moreYahoo Finance • 2 days ago
Humana initiated, Paycom upgraded: Wall Street's top analyst calls
Yahoo Finance • 2 days ago
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
Yahoo Finance • 2 days ago
Communiqué de presse : Sanofi et Regeneron voient l’autorisation du Dupixent pour le traitement de l’urticaire chronique spontanée progresser dans l’UE grâce à un avis positif du CHMP
Yahoo Finance • 2 days ago
Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion
About
CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
CFO | Mr. Christopher R. Fenimore CPA |
Address | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15,182 |
